Valproate use in women aged 15–44 years: an observational study in general practice
Background: Valproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted its use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To date, there is limited information on valproate prescribing wit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Royal College of General Practitioners
|
| Series: | BJGP Open |
| Subjects: | |
| Online Access: | https://bjgpopen.org/content/5/2/BJGPO.2020.0104 |